Map2k6 as modifier of branching morphogenesis and methods of use
    21.
    发明申请
    Map2k6 as modifier of branching morphogenesis and methods of use 审中-公开
    Map2k6作为分支形态发生的调节剂和使用方法

    公开(公告)号:US20070092875A1

    公开(公告)日:2007-04-26

    申请号:US10532432

    申请日:2003-10-22

    申请人: Gregory Plowman

    发明人: Gregory Plowman

    IPC分类号: C12Q1/68 G01N33/574

    摘要: Human MAP2K6 genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morphogenesis, comprising screening for agents that modulate the activity of MAP2K6 are provided.

    摘要翻译: 人MAP2K6基因被鉴定为分支形态发生的调节剂,因此是与缺陷支链形态发生功能相关的病症的治疗靶点。 提供了用于鉴定分支形态发生调节剂的方法,包括筛选调节MAP2K6活性的试剂。

    Diagnosis and treatment of AUR1 and/or AUR2 related disorders
    23.
    发明授权
    Diagnosis and treatment of AUR1 and/or AUR2 related disorders 失效
    诊断和治疗AUR1和/或AUR2相关疾病

    公开(公告)号:US06716575B2

    公开(公告)日:2004-04-06

    申请号:US09012135

    申请日:1998-01-22

    IPC分类号: C12Q168

    摘要: The present invention relates to AUR1 and/or AUR2 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for AUR1 and/or AUR2 related diseases or conditions characterized by an abnormal interaction between a AUR1 and/or AUR2 polypeptide and a AUR1 and/or AUR2 binding partner.

    摘要翻译: 本发明涉及AUR1和/或AUR2多肽,编码此类多肽的核酸,含有此类核酸的细胞,组织和动物,此类多肽的抗体,利用此类多肽的测定法以及与上述所有相关的方法。 AUR1和/或AUR2相关疾病或特征为AUR1和/或AUR2多肽与AUR1和/或AUR2结合配偶体之间异常相互作用的病症的治疗,诊断和筛选方法。

    Polynucleotides encoding STE20-related protein kinases and methods of use
    24.
    发明授权
    Polynucleotides encoding STE20-related protein kinases and methods of use 失效
    编码STE20相关蛋白激酶的多核苷酸及其使用方法

    公开(公告)号:US06680170B2

    公开(公告)日:2004-01-20

    申请号:US09291417

    申请日:1999-04-13

    IPC分类号: C12Q168

    CPC分类号: C12N9/1205 A61K38/00

    摘要: The present invention relates to the nucleic acid molecules encoding an STE20-related family of novel protein kinases, ZC1, ZC2, ZC3, ZC4, STLK2, STLK3, STLK4, STLK5, STLK6, STLK7, KHS2, SULU1, SULU3, GEK2, PAK4 and PAK5, segments and domains thereof, as well as various methods useful for the diagnosis and treatment of various kinase-related diseases and conditions. Mammalian nucleic acid molecules encoding these kinases are particularly disclosed, and more specifically human sources of these nucleic acids are disclosed.

    摘要翻译: 本发明涉及编码STE20相关家族新型蛋白激酶ZC1,ZC2,ZC3,ZC4,STLK2,STLK3,STLK4,STLK5,STLK6,STLK7,KHS2,SULU1,SULU3,GEK2,PAK4的核酸分子和 PAK5,其片段和结构域,以及可用于诊断和治疗各种激酶相关疾病和病症的各种方法。 特别公开了编码这些激酶的哺乳动物核酸分子,更具体地公开了这些核酸的人源。

    Polypeptide fragments of human PAK5 protein kinase
    25.
    发明授权
    Polypeptide fragments of human PAK5 protein kinase 失效
    人PAK5蛋白激酶的多肽片段

    公开(公告)号:US06656716B1

    公开(公告)日:2003-12-02

    申请号:US09688188

    申请日:2000-10-16

    IPC分类号: C12N912

    CPC分类号: C12N9/1205 A61K38/00

    摘要: The present invention related to the novel human kinase polypeptides STLK2, STLK3, STLK4, STLK5, STLK6, STLK7, ZC1, ZC2, ZC3, ZC4, KHS2, SULU1, SULU2, SULU3, GEK2, PAK4, and PAK5, nucleotide sequences encoding the novel kinase polypeptides, as well as various products and methods useful for the diagnosis and treatment of various kinase-related diseases and conditions.

    摘要翻译: 本发明涉及新型人激酶多肽STLK2,STLK3,STLK4,STLK5,STLK6,STLK7,ZC1,ZC2,ZC3,ZC4,KHS2,SULU1,SULU2,SULU3,GEK2,PAK4和PAK5, 激酶多肽,以及可用于诊断和治疗各种激酶相关疾病和病症的各种产物和方法。

    Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof
    26.
    发明申请
    Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof 审中-公开
    编码PAK5多肽的核酸及其使用方法

    公开(公告)号:US20070072261A1

    公开(公告)日:2007-03-29

    申请号:US10725330

    申请日:2003-12-02

    IPC分类号: C12P21/06 C12N9/12 C07H21/04

    CPC分类号: C12N9/1205 A61K38/00

    摘要: The present invention relates to the nucleic acid molecules encoding an STE20-related family of novel protein kinases, ZC1, ZC2, ZC3, ZC4, STLK2, STLK3, STLK4, STLK5, STLK6, STLK7, KHS2, SULU1, SULU3, GEK2, PAK4 and PAK5, segments and domains thereof, as well as various methods useful for the diagnosis and treatment of various kinase-related diseases and conditions. Mammalian nucleic acid molecules encoding these kinases are particularly disclosed, and more specifically human sources of these nucleic acids are disclosed.

    摘要翻译: 本发明涉及编码STE20相关家族新型蛋白激酶ZC1,ZC2,ZC3,ZC4,STLK2,STLK3,STLK4,STLK5,STLK6,STLK7,KHS2,SULU1,SULU3,GEK2,PAK4的核酸分子和 PAK5,其片段和结构域,以及可用于诊断和治疗各种激酶相关疾病和病症的各种方法。 特别公开了编码这些激酶的哺乳动物核酸分子,更具体地公开了这些核酸的人源。

    Mammalian protein phosphatases
    30.
    发明申请
    Mammalian protein phosphatases 审中-公开
    哺乳动物蛋白磷酸酶

    公开(公告)号:US20050054070A1

    公开(公告)日:2005-03-10

    申请号:US10716442

    申请日:2003-11-20

    IPC分类号: A61K38/00 C12N9/16 C07H21/04

    CPC分类号: C12N9/16 A61K38/00

    摘要: The present invention relates to phosphatase polypeptides, nucleotide sequences encoding the phosphatase polypeptides, as well as various products and methods useful for the diagnosis and treatment of various phosphatase-related diseases and conditions. Through the use of a bioinformatics strategy, mammalian members of the MAP kinase phosphatase PTP's and STP's have been identified and their protein structure predicted.

    摘要翻译: 本发明涉及磷酸酶多肽,编码磷酸酶多肽的核苷酸序列,以及可用于诊断和治疗各种磷酸酶相关疾病和病症的各种产品和方法。 通过使用生物信息学策略,已经鉴定了MAP激酶磷酸酶PTP和STP的哺乳动物成员,并预测了其蛋白质结构。